Cognex (NASDAQ:CGNX) Releases Q3 2025 Earnings Guidance

Key Points

• Cognex updated its Q3 2025 earnings guidance, projecting earnings per share (EPS) in the range of 0.240-0.290 and revenue of $245.0 million-$265.0 million, slightly below consensus estimates.
• Trading at $33.76 per share, Cognex experienced a decrease during mid-day trading, with analysts showing a consensus rating of "Hold" and an average target price of $40.25.
• Institutional investors currently hold 88.12% of Cognex's stock, with significant transactions including a 402.2% increase in stakes by Geneos Wealth Management in the first quarter.

Cognex (NASDAQ:CGNX - Get Free Report) updated its third quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of 0.240-0.290 for the period, compared to the consensus EPS estimate of 0.243. The company issued revenue guidance of $245.0 million-$265.0 million, compared to the consensus revenue estimate of $250.1 million.

Cognex Stock Down 1.3%

Shares of Cognex stock traded down $0.52 on Friday, hitting $40.25. The stock had a trading volume of 1,737,995 shares, compared to its average volume of 2,092,419. The stock has a market cap of $6.76 billion, a price-to-earnings ratio of 56.69 and a beta of 1.47. Cognex has a twelve month low of $22.67 and a twelve month high of $44.17. The business's 50 day moving average is $31.81 and its two-hundred day moving average is $31.81.

Cognex (NASDAQ:CGNX - Get Free Report) last released its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.02. The firm had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. Cognex had a return on equity of 6.64% and a net margin of 13.13%. The company's revenue was up 4.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.23 EPS. As a group, equities analysts predict that Cognex will post 0.61 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th will be paid a $0.08 dividend. The ex-dividend date is Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.8%. Cognex's dividend payout ratio (DPR) is presently 45.07%.

Analysts Set New Price Targets

Several brokerages recently weighed in on CGNX. DA Davidson restated a "neutral" rating and set a $32.00 price objective on shares of Cognex in a research report on Monday, June 16th. Needham & Company LLC increased their target price on shares of Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a report on Thursday. The Goldman Sachs Group raised their price target on shares of Cognex from $29.00 to $32.00 and gave the company a "sell" rating in a research note on Thursday, June 12th. Melius raised shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price target for the company in a research note on Thursday, July 10th. Finally, TD Cowen upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $35.00 target price on the stock in a report on Monday, April 28th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $42.08.

Hedge Funds Weigh In On Cognex

A number of hedge funds have recently bought and sold shares of CGNX. Geneos Wealth Management Inc. raised its holdings in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after purchasing an additional 736 shares during the last quarter. Empowered Funds LLC bought a new stake in Cognex in the 1st quarter worth about $291,000. Intech Investment Management LLC increased its stake in Cognex by 24.1% in the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company's stock valued at $1,415,000 after buying an additional 9,223 shares during the last quarter. Finally, Royal Bank of Canada increased its stake in Cognex by 13.2% in the 1st quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company's stock valued at $5,976,000 after buying an additional 23,326 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.